What are ADBT's recent SEC filings?
Ferdinand Groenewald resigned from the Board of Directors of Advasa Holdings, Inc., including all committee appointments, effective October 26, 2026. The company stated the resignation was for personal reasons and not due to any disagreements with management or the Board.
View full filing details →Advasa Holdings received a Nasdaq notice on October 21, 2026, stating its common stock traded below the $1.00 minimum bid price for 30 consecutive business days. The company has until April 19, 2027 to regain compliance or potentially transfer to the Nasdaq Capital Market.
View full filing details →Advasa Holdings announced that its largest stockholder, Mr. Asamitsu Kosugi, intends to surrender 97,413,140 shares of common stock to the company for no consideration, which would reduce outstanding shares by approximately 20%. The transaction is subject to final documentation, corporate approvals, and transfer agent procedures, and has not yet been completed.
View full filing details →Advasa Holdings announced a new dividend policy targeting a 50% annual payout ratio of net income attributable to common stockholders, beginning with the fiscal year ending March 31, 2027. No dividend has been declared yet, and any future dividends remain subject to Board approval and various conditions.
View full filing details →Advasa Holdings announced five-year medium-term operating goals through fiscal 2031, targeting consolidated revenue of USD 632.91 million and operating income of USD 189.87 million by fiscal 2031, up from USD 18.99 million revenue and USD 1.90 million operating income targeted for fiscal 2027.
View full filing details →Advasa Holdings, Inc. entered into an Executive Employment Agreement with William Witherspoon to serve as Chief Financial Officer, effective October 6, 2026, with an initial annual base salary of $200,000.
View full filing details →Has ADBT ever done a stock split?
No stock splits are recorded for ADBT.
What is ADBT's share float?
Get Real-Time ADBT Intelligence
SEPT X-Ray combines SEC filings with price targets, support/resistance levels, and smart money tracking — updated every 30 minutes.
Try SEPT X-Ray Free